XPeng Inc.
NYSE:XPEVAuto - Manufacturers
-$0.40 today
- Market cap
- $9.25B
- Beta
- 1.08
- P/E (TTM)
- -37.8
- EPS (TTM)
- -$1.18
Volume 8.06M
Average 6.75M
XPEV EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
XPeng Inc.NYSE: XPEV
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA remains negative
Q3 FY2026 EBITDA was -CN¥734.62M, compared with -CN¥294.35M a year earlier. Trailing-twelve-month EBITDA was -CN¥3.18B.
Context
- EBITDA amounted to 2.9% of revenue in FY2025, down 4.2 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 13 analysts of CN¥3.3B (+49.4%) for the fiscal year ending Dec 2026, a slowdown from the +175.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -CN¥734.62M+44.5% QoQ
- Last fiscal yearDec 2025
- CN¥2.21B+175.9% YoY
- LTMSep 2026
- -CN¥3.18B-26.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -149.6% | +115.2% | +264.7 pp |
| 1 year | +175.9% | +49.4% | -126.5 pp |
| 3-year CAGR | — | +61.3% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
CNY · from the income statement
- Latest · FY2025
- 2.21B CNY
- Year-over-year change
- +175.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.21B | +175.9% |
| FY2024 | 2024-12-31 | (2.91B) | +63.7% |
| FY2023 | 2023-12-31 | (8.02B) | -5.8% |
| FY2022 | 2022-12-31 | (7.58B) | -92.1% |
| FY2021 | 2021-12-31 | (3.94B) | — |
EBITDA vs competitors
How XPEV compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -26.0% is the 7th highest of 11, against a peer median of -17.6%.
- EBITDA amounts to 4.0% of revenue for XPEV, versus a peer median of 12.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥7.45T JPY | -7.9% | +10.4% | 14.2% | |
| LTM Sep 2026 | $15.04B USD | -20.4% | -8.3% | 8.0% | |
| LTM Sep 2026 | $11.27B USD | -14.7% | -12.3% | 10.9% | |
| LTM Dec 2025 | -$359.61M USD | +62.9% | — | 69.2% | |
| LTM Jun 2026 | -$1.78B USD | -116.0% | — | 0.9% | |
| LTM Jun 2026 | -$2.14B USD | +7.4% | — | 36.4% | |
| LTM Jun 2026 | -CN¥2.54B CNY | -119.4% | — | 2.4% | |
| LTM Mar 2026 | -$2.77B USD | -35.8% | — | 197.5% | |
| LTM Sep 2026 | -CN¥3.18B CNY | -26.0% | — | 4.0% | |
| LTM Jun 2026 | -CN¥3.47B CNY | +75.6% | — | 3.0% | |
| LTM Mar 2026 | -₫73.27T VND | -55.7% | — | 75.4% | |
| Peer median (excluding XPEV) | — | -17.6% | -8.3% | 12.5% | |
Competitors are the stored peer set for XPEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 20.99B | 26.86B | 30.68B | 40.87B | 76.72B |
| Cost of Revenue | 18.37B | 23.77B | 30.22B | 35.02B | 62.25B |
| Gross Profit | 2.62B | 3.09B | 451.16M | 5.85B | 14.47B |
| Gross Margin | 12.5% | 11.5% | 1.5% | 14.3% | 18.9% |
| Research & Development | 4.11B | 5.21B | 5.28B | 6.46B | 9.49B |
| Selling, General & Admin | 5.31B | 6.69B | 6.56B | 6.87B | 9.4B |
| Operating Expenses | 9.2B | 11.79B | 11.34B | 12.5B | 17.13B |
| Depreciation & Amortization | 837.8M | 1.41B | 2.11B | 2.57B | 2.99B |
| EBITDA | (3.94B) | (7.58B) | (8.02B) | (2.91B) | 2.21B |
| EBITDA Margin | -18.8% | -28.2% | -26.1% | -7.1% | 2.9% |
| Operating Income | (6.58B) | (8.71B) | (10.89B) | (6.66B) | (2.65B) |
| Operating Margin | -31.3% | -32.4% | -35.5% | -16.3% | -3.5% |
| Interest Income | 743.03M | 1.06B | 1.26B | 1.37B | 1.16B |
| Interest Expense | 55.34M | 132.19M | 268.67M | 343.98M | 379.93M |
| Other Income / Expenses | 1.74B | (408.72M) | 550.47M | 798.09M | 1.53B |
| Income Before Tax | (4.84B) | (9.11B) | (10.34B) | (5.86B) | (1.13B) |
| Pre-Tax Margin | -23.0% | -33.9% | -33.7% | -14.3% | -1.5% |
| Income Tax Expense | 25.99M | 24.73M | 36.81M | (69.78M) | 13.59M |
| Net Income | (4.86B) | (9.14B) | (10.38B) | (5.79B) | (1.14B) |
| Net Margin | -23.2% | -34.0% | -33.8% | -14.2% | -1.5% |
| EPS (Basic) | (5.92) | (10.68) | (11.92) | (6.12) | (2.40) |
| EPS (Diluted) | (5.92) | (10.68) | (11.92) | (6.12) | (2.40) |
| Weighted Avg Shares | 821.45M | 856.27M | 870.46M | 945.68M | 476M |
| Weighted Avg Shares (Diluted) | 821.45M | 856.27M | 870.46M | 945.68M | 476M |
XPeng Inc.
NYSE:XPEV
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.